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A commentary on
Transient activation of autophagy via
sox2-mediated suppression ofmTOR is an
important early step in reprogramming to
pluripotency
by Wang, S., Xia, P., Ye, B., Huang, G., Liu,
J., and Fan, Z. (2013). Cell Stem Cell 13,
617–625. doi: 10.1016/j.stem.2013.10.005
Nuclear reprogramming to achieve
induced-pluripotency by the Yamanaka
factors (Takahashi and Yamanaka, 2006)
is largely viewed as a consequence of a
cascade of expression profile changes,
along with alterations in epigenetic mark-
ings, which are primarily nuclear events.
Cytoplasmic processes that could be
critical for this process have not been
emphasized. However, Fan and colleagues
now showed that macroautophagy (or
simply autophagy), regulated through the
suppression of mTOR expression by Sox2,
is required for nuclear reprogramming and
induced pluripotent stem cell (iPSC) for-
mation (Wang et al., 2013). These findings
are in general agreement with two earlier
reports. The first of which had shown that
the mTOR inhibitor rapamycin enhanced
iPSC generation (Chen et al., 2011), while
the other demonstrated that reprogram-
ming requires delicate modulation of
mTOR levels and activity (He et al., 2012).
The authors has an elegant system of
fibroblast harboring the Yamanaka fac-
tors (or OKSM factors—Oct4, Klf4, Sox-2,
and c-Myc) that are doxycycline inducible.
They observed that reprogramming to
iPSCs is impaired in fibroblasts depleted
of critical autophagy factors, such as Atg3,
Atg5, and Atg7. There is an increase in
the rate of autophagy, as indicated by the
accumulation of LC3 puncta, within a day
after doxycycline addition, and this peaked
in day 2. The levels of the Atg proteins
are not altered during iPSC induction, but
mechanistic target of rapamycin (mTOR)
transcript and protein levels, as well as
readouts of its kinase activity, declined at
the earlier stage of induction. The timing
of this mTOR suppression is important, as
the mTOR inhibitor rapamycin enhanced
iPSC formation when administered at day
1 of induction, but inhibited iPSC forma-
tion when given 3 days after. Of the four
Yamanaka factors, only ectopic expression
of Sox2 could suppress mTOR expres-
sion. Interestingly, this occurs in fibrob-
lasts, but not seen with cell lines such as
HeLa or HEK293. The authors’ observa-
tion has an important physiological cor-
relate in early embryonic development,
as they observed that autophagy is also
induced in the 4–8 cell stage of developing
embryos.
How does Sox2 suppress mTOR
expression during the early stage of iPSC
induction? The authors identified a Sox2
binding site at a region about 1.6 kbp
upstream of the transcription start site
of the mTOR gene. Deletion of this site
using TALEN-based genome editing abol-
ished Sox2 suppression of mTOR and
autophagy induction, and the mutated
cells could not generate iPSCs. That Sox2
suppression of mTOR expression at an
early stage of induction is critical for iPSC
production is further corroborated by the
demonstration that inducible silencing
of mTOR at the early stage bypassed the
need for Sox2. The authors showed further
that Sox2 act by recruiting the nucleosome
remodeling deacetylase (NuRD) complex
(Hu and Wade, 2012) to the repressor cis
element of mTOR’s promoter. Silencing
of NuRD components restored mTOR
expression, impairing autophagy induc-
tion and iPSC generation. The association
of the repressor complex with mTOR pro-
moter is dynamic, and the association is
lost 3 days after iPSC induction. Again
the physiological correlation between the
in vitro fibroblast system and 4–8 cell stage
embryos holds true, as NuRD is also found
to be recruited to the mTOR promoter of
embryos at this stage.
The findings of Fan and colleagues
highlighted a crucial role for autophagy
during nuclear reprogramming, and deci-
phered the underlying mechanism of how
timely onset of autophagy during repro-
gramming is regulated through mTOR
suppression by Sox2-NuRD. This regula-
tory mechanism is likely to be cell type
dependent, or at least limited to untrans-
formed cells. Another recent report has
shown that iPSC-like cells generated by
reprogramming of MCF-7 breast cancer
cells have high expression of endogenous
Sox2 (Corominas-Faja et al., 2013). This
was, however, associated with transcrip-
tional suppression of mTOR repressors,
and consequentially an increased mTOR
activity. Whether there was a decrease in
mTOR activity at the very early stages of
MCF-7 iPSC induction was unclear.
mTOR is a focal regulatory point of
cellular homeostasis, and are linked to
multiple signaling pathways that might
impact on reprogramming. However
it does appear that autophagy induced
by mTOR suppression per se is critical
for nuclear reprogramming in culture.
Autophagy is known to be essential for
early, preimplantation embryonic devel-
opment, and Atg5-deficient embryos
could not develop beyond the 4–8 cell
stage (Tsukamoto et al., 2008). These
findings beg the questions of why and
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how does autophagy augment repro-
gramming in vitro and in vivo. There are
several possibilities. In drawing parallels
between the transformation of fibroblasts
to iPSCs with differentiation of precur-
sor cells to adipocytes or erythrocytes,
Vessoni and colleagues have postulated
that extensive cellular remodeling in the
cytoplasm is required in the establishment
of induced pluripotency (Vessoni et al.,
2012). One such remodeling involves
reduction of mitochondria number, as
iPSCs, like embryonic stem cells (ESCs),
have reduced mitochondrial mass and
reactive oxygen species (ROS) produc-
tion (Armstrong et al., 2010; Prigione
et al., 2010). As iPSCs are supposed to
be rejuvenated from cumulative cellular
and genetic damages found in its precur-
sors, autophagy is an obvious mechanism
whereby this rejuvenation could conceiv-
ably be achieved.Materials scavenged from
autophagy could also provide anabolic
building blocks and energy that would
be channeled toward cellular remodeling.
Autophagy-dependent cellular remodeling
is conceivably also required during early
embryonic development. This notion,
however, does not address why mTOR
suppression and autophagy induction is
required at the very early stages of iPSC
induction.
Another possible connection is the
potential ability of autophagy to enhance
cell survival and alleviate apoptosis and/or
senescence. Menendez and colleagues have
argued that “forced expression of the
Yamanaka cocktail of stemness factors is
a stressful process that activates apoptosis
and cellular senescence” (Menendez et al.,
2011). The latter processes are mediated by
the tumor suppressor p53 and its down-
stream effectors, which are known barri-
ers to reprogramming (Hong et al., 2009;
Marión et al., 2009; Li et al., 2013). p53-
mediated inhibition of reprogramming
was postulated as a mechanism that might
ensure genomic integrity of the pluripo-
tent stem cells produced by programming.
It appears that a parallel process occurs
in the cytoplasm to ensure integrity of
the structural and functional proteome
in reprogrammed stem cells. There are
tantalizing clues that these two processes
crosstalk with each other. Identification of
the points of connection between them
would be of tremendous academic inter-
est, and will undoubtedly also facilitate the
efficacy and quality of iPSC production
in vitro.
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